SR ONE CAPITAL MANAGEMENT, LLC
29 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-05-11 | ODTX | Odyssey Therapeutics, Inc. | Buy | 222,222 | $18.00 | $4.0M | filing |
| 2026-05-11 | ODTX | Odyssey Therapeutics, Inc. | Buy | 200,000 | $18.00 | $3.6M | filing |
| 2026-05-11 | ODTX | Odyssey Therapeutics, Inc. | Buy | 133,333 | $18.00 | $2.4M | filing |
| 2026-05-11 | ODTX | Odyssey Therapeutics, Inc. | Sale | 1,065 | $18.00 | $19,170.00 | filing |
| 2026-05-11 | ODTX | Odyssey Therapeutics, Inc. | Sale | 438 | $18.00 | $7,884.00 | filing |
| 2026-05-11 | ODTX | Odyssey Therapeutics, Inc. | Sale | 277 | $18.00 | $4,986.00 | filing |
| 2026-05-11 | ODTX | Odyssey Therapeutics, Inc. | C | 118,512 | — | — | filing |
| 2026-05-11 | ODTX | Odyssey Therapeutics, Inc. | C | 255,823 | — | — | filing |
| 2026-05-11 | ODTX | Odyssey Therapeutics, Inc. | C | 204,658 | — | — | filing |
| 2026-05-11 | ODTX | Odyssey Therapeutics, Inc. | C | 20,582 | — | — | filing |
| 2026-05-11 | ODTX | Odyssey Therapeutics, Inc. | C | 166,168 | — | — | filing |
| 2026-05-11 | ODTX | Odyssey Therapeutics, Inc. | X | 49,850 | — | — | filing |
| 2026-05-11 | ODTX | Odyssey Therapeutics, Inc. | C | 463,106 | — | — | filing |
| 2026-05-11 | ODTX | Odyssey Therapeutics, Inc. | C | 273,527 | — | — | filing |
| 2026-05-11 | ODTX | Odyssey Therapeutics, Inc. | X | 78,656 | — | — | filing |
| 2026-05-11 | ODTX | Odyssey Therapeutics, Inc. | C | 474,048 | — | — | filing |
| 2026-05-11 | ODTX | Odyssey Therapeutics, Inc. | C | 139,366 | — | — | filing |
| 2026-05-11 | ODTX | Odyssey Therapeutics, Inc. | C | 59,692 | — | — | filing |
| 2026-05-11 | ODTX | Odyssey Therapeutics, Inc. | C | 61,762 | — | — | filing |
| 2026-05-11 | ODTX | Odyssey Therapeutics, Inc. | C | 683,817 | — | — | filing |
| 2026-05-11 | ODTX | Odyssey Therapeutics, Inc. | X | 191,541 | — | — | filing |
| 2026-05-01 | AVLN | Avalyn Pharma Inc. | Buy | 277,778 | $18.00 | $5.0M | filing |
| 2026-05-01 | AVLN | Avalyn Pharma Inc. | Buy | 277,777 | $18.00 | $5.0M | filing |
| 2026-05-01 | AVLN | Avalyn Pharma Inc. | C | 354,824 | — | — | filing |
| 2026-05-01 | AVLN | Avalyn Pharma Inc. | C | 489,486 | — | — | filing |
| 2026-05-01 | AVLN | Avalyn Pharma Inc. | C | 1,419,298 | — | — | filing |
| 2026-05-01 | AVLN | Avalyn Pharma Inc. | C | 489,486 | — | — | filing |
| 2025-10-09 | ZBIO | Zenas BioPharma, Inc. | Buy | 63,158 | $19.00 | $1.2M | filing |
| 2025-10-09 | ZBIO | Zenas BioPharma, Inc. | Buy | 63,157 | $19.00 | $1.2M | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.